Stop Signal Reaction Time measured with a portable device validates optimum STN-DBS programming

Stop Signal Reaction Time measured with a portable device validates optimum STN-DBS programming

Bibliographic Details
Main Authors:	Akash Roy, Supriyo Choudhury, Purba Basu, Mark R. Baker, Stuart N. Baker, Hrishikesh Kumar
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Brain Stimulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1935861X20302461

Similar Items

The Dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease
by: Anna Castrioto, et al.
Published: (2011-01-01)

Comparison of GPi-DBS, STN-DBS, and pallidotomy in primary Meige syndrome
by: Qingpei Hao, et al.
Published: (2023-09-01)

Predicting Outcome Of DBS-STN With Machine Learning Radiomics
by: Dimitrios Giakoumettis, et al.
Published: (2023-01-01)

Rescue GPi-DBS for a Stroke Associated Hemiballism in a Patient with STN-DBS
by: Genko Oyama, et al.
Published: (2014-02-01)

Effects of Diazepam on Reaction Times to Stop and Go
by: Swagata Sarkar, et al.
Published: (2020-10-01)

The effects of STN-DBS on motor speech: A longitudinal articulographic study
by: Tabea Thies, et al.
Published: (2023-11-01)

Differential spatiotemporal gait effects with frequency and dopaminergic modulation in STN-DBS
by: Ritesh A. Ramdhani, et al.
Published: (2023-09-01)

STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
by: Antti Huotarinen, et al.
Published: (2017-12-01)

Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor
by: Raminder Parihar, et al.
Published: (2015-07-01)

Somatotopic organization of STN and DBS implications in Parkinson’s disease - A case report of a woman “halved” by DBS stimulation
by: D. Alimonti, et al.
Published: (2020-09-01)

STN-DBS reduces saccadic hypometria but not visuospatial bias in Parkinson’s disease patients
by: Fischer, P, et al.
Published: (2016)

STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson’s disease
by: Francesco Bove, et al.
Published: (2022-06-01)

Subjective assessments of voice in parkinson's disease subjects with and without STN-DBS therapy
by: Halil Onder, et al.
Published: (2023-01-01)

New Onset On-Medication Freezing of Gait After STN-DBS in Parkinson's Disease
by: Shanshan Mei, et al.
Published: (2019-06-01)

Learning from negative consequences is impaired by STN-DBS and levodopa in Parkinson’s disease
by: Abhinav Raina, et al.
Published: (2021-01-01)

Effects of STN‐DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease
by: Ganhua Luo, et al.
Published: (2023-08-01)

To do or don’t, to take or don’t take: STN-DBS therapy in young PD patient
by: Şenol Mehmet Güney, et al.
Published: (2020-01-01)

NIH Toolbox performance of persons with Parkinson's disease according to GBA1 and STN‐DBS status
by: Ahmad Almelegy, et al.
Published: (2024-04-01)

A rare patient with STN-DBS presenting with dela-onset and persistent peri-lead edema
by: Halil Onder, et al.
Published: (2023-01-01)

Acute reduction of β band functional connectivity induced by STN-DBS in patients with Parkinson’s disease
by: Matteo Conti, et al.
Published: (2023-01-01)

Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease
by: Haitao Li, et al.
Published: (2020-01-01)

Prediction of STN-DBS Electrode Implantation Track in Parkinson’s Disease by Using Local Field Potentials
by: Ilknur eTelkes, et al.
Published: (2016-05-01)

Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease
by: Kevin B. Wilkins, et al.
Published: (2020-12-01)

Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
by: Haitao Li, et al.
Published: (2020-01-01)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
by: Matteo Conti, et al.
Published: (2022-11-01)

Acute and Chronic Mood and Apathy Outcomes from a randomized study of unilateral STN and GPi DBS.
by: Michael S Okun, et al.
Published: (2014-01-01)

Low-dose clozapine-induced agranulocytosis in patients with movement disorders—Retrospective study from India
by: Supriyo Choudhury, et al.
Published: (2021-01-01)

Effects of STN-DBS on cognition and mood in young-onset Parkinson’s disease: a two-year follow-up
by: Jun Hong, et al.
Published: (2024-01-01)

Hot and Cold Cognitive Disturbances in Parkinson Patients Treated with DBS-STN: A Combined PET and Neuropsychological Study
by: Louise M. Jørgensen, et al.
Published: (2022-05-01)

Voice worsening in post deep brain stimulation parkinson's patients - Is deep brain stimulation (DBS-STN) the culprit?
by: Jitesh Goel, et al.
Published: (2023-01-01)

Outcomes of STN-DBS in PD Patients With Different Rates of Disease Progression Over One Year of Follow-Up
by: Renli Qi, et al.
Published: (2020-07-01)

Motor symptom asymmetry predicts non-motor outcome and quality of life following STN DBS in Parkinson's disease
by: Philippe Voruz, et al.
Published: (2022-02-01)

Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
by: Banashree Mondal, et al.
Published: (2021-05-01)

Retraction Note: Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
by: Banashree Mondal, et al.
Published: (2022-11-01)

STN local field potential recordings from awake patients with Parkinson’s, ON and OFF meds, and during 130 Hz DBS
by: Wiest, C, et al.
Published: (2022)

Changes in optimal stimulation frequency with time for gait disturbances in patients with PD after STN-DBS—A longitudinal study
by: Sruthi Kola, et al.
Published: (2023-01-01)

Randomized, Double-Blind Assessment of LFP Versus SUA Guidance in STN-DBS Lead Implantation: A Pilot Study
by: Musa Ozturk, et al.
Published: (2020-06-01)

Effects of antidromic and orthodromic activation of STN afferent axons during DBS in Parkinson's disease: a simulation study
by: Guiyeom eKang, et al.
Published: (2014-03-01)

Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease
by: Banashree Mondal, et al.
Published: (2024-02-01)

Effects of deep brain stimulation in the subthalamic nucleus (STN-DBS) on cellular plasticity in catecholaminergic systems in a hemiparkinsonian rat model
by: Meike Statz, et al.
Published: (2023-01-01)